StocksMedium•28 September 2026•
1 min read
US Court Denies Pfizer and Moderna Bid to Dismiss Bayer Vaccine Patent Lawsuit
Key Facts
1A U.S. court denied requests from Pfizer, BioNTech, and Moderna to dismiss a patent infringement lawsuit filed by Bayer regarding COVID-19 vaccines.
A U.S. court denied requests from Pfizer, BioNTech, and Moderna to dismiss a patent infringement lawsuit filed by Bayer regarding COVID-19 vaccines. Investing.com reported that a federal judge ruled the case can proceed to the next phase, as the court found sufficient grounds for Bayer's claims that mRNA vaccines infringe on its existing patents.
BAYRY closed at $14.32 on September 25, 2026, while PFE closed at $28.67 on the same date. MRNA closed at $198.88 on September 25, 2026, as the vaccine manufacturers now face legal risks and potential damages following the court's decision to allow the litigation to continue.